acut
respiratori
infect
ari
among
lead
caus
background
hospit
children
year
old
rapid
diagnost
viral
pathogen
essenti
avoid
unnecessari
antibiot
treatment
therebi
slow
antibioticresist
evalu
diagnost
perform
luminex
xtag
respiratori
viral
panel
fast
viral
specif
pcr
refer
assay
ari
vietnam
four
hundr
forti
two
nose
throat
swab
collect
method
viral
transport
medium
test
luminex
xtag
respiratori
viral
panel
fast
multiplex
rtpcr
singl
rtpcr
use
refer
overal
sensit
luminex
refer
assay
result
ci
whilst
ci
pathogen
detect
luminex
refer
assay
frequenc
pathogen
detect
luminex
refer
assay
respect
diagnost
yield
ci
luminex
assay
ci
refer
assay
luminex
kit
higher
yield
virus
except
influenza
b
viru
respiratori
syncyti
viru
human
bocaviru
high
agreement
method
mean
rang
pubm
abstract
publish
full
text
free
full
text
william
bg
gouw
e
boschipinto
c
et
al
estim
worldwid
distribut
child
death
acut
respiratori
infect
lancet
infect
di
pubm
abstract
publish
full
text
ander
kl
nguyen
hl
nguyen
nm
et
al
epidemiolog
virolog
acut
respiratori
infect
first
year
life
birth
cohort
studi
vietnam
pediatr
infect
di
j
pubm
abstract
publish
full
text
free
full
text
van
gageldonklafeb
ab
heijnen
ml
barteld
ai
et
al
casecontrol
studi
acut
respiratori
tract
infect
gener
practic
patient
netherland
clin
infect
di
pubm
abstract
publish
full
text
chou
ca
lin
ti
chen
ys
et
al
comparison
etiolog
diagnost
tool
lower
respiratori
tract
infect
hospit
young
children
southern
taiwan
two
season
j
microbiol
immunol
infect
pubm
abstract
publish
full
text
moesker
fm
van
kampen
jj
van
rossum
et
al
virus
sole
caus
agent
sever
acut
respiratori
tract
infect
children
plo
one
pubm
abstract
publish
full
text
free
full
text
fujitsuka
tsukagoshi
h
arakawa
et
al
molecular
epidemiolog
studi
respiratori
virus
detect
japanes
children
acut
wheez
ill
bmc
infect
di
pubm
abstract
publish
full
text
free
full
text
mishra
p
nayak
l
da
rr
et
al
viral
agent
caus
acut
respiratori
infect
children
five
studi
eastern
india
int
j
pediatr
pubm
abstract
publish
full
text
free
full
text
liao
rs
tomalti
majuri
et
al
comparison
viral
isol
multiplex
realtim
revers
transcriptionpcr
confirm
respiratori
syncyti
viru
influenza
viru
detect
antigen
immunoassay
j
clin
microbiol
pubm
abstract
publish
full
text
free
full
text
advani
sengupta
forman
et
al
detect
respiratori
virus
asymptomat
children
pediatr
infect
di
j
pubm
abstract
publish
full
text
free
full
text
aguilar
jc
mp
garcia
ml
et
al
detect
identif
human
parainfluenza
virus
clinic
sampl
pediatr
patient
multiplex
revers
transcriptionpcr
j
clin
microbiol
pubm
abstract
free
full
text
baladallasat
jm
laru
h
kelli
c
et
al
evalu
commerci
resplex
ii
multicodeplx
xtag
respiratori
viral
panel
diagnosi
respiratori
viral
infect
adult
j
clin
virol
pubm
abstract
publish
full
text
mahoni
jb
blackhous
g
babwah
j
et
al
cost
analysi
multiplex
pcr
test
diagnos
respiratori
viru
infect
j
clin
microbiol
pubm
abstract
publish
full
text
free
full
text
freymuth
f
vabret
cuvillonnim
et
al
comparison
multiplex
pcr
assay
convent
techniqu
diagnost
respiratori
viru
infect
children
admit
hospit
acut
respiratori
ill
j
med
virol
pubm
abstract
publish
full
text
gadsbi
nj
hardi
claa
ec
et
al
comparison
luminex
respiratori
viru
panel
fast
assay
inhous
realtim
pcr
respiratori
viral
infect
diagnosi
j
clin
microbiol
pubm
abstract
publish
full
text
free
full
text
popowitch
eb
oneil
ss
miller
mb
comparison
biofir
filmarray
rp
genmark
esensor
rvp
luminex
xtag
luminex
xtag
rvp
fast
multiplex
assay
detect
respiratori
virus
j
clin
microbiol
pubm
abstract
publish
full
text
free
full
text
pabbaraju
k
wong
tokaryk
kl
et
al
comparison
luminex
xtag
respiratori
viral
panel
xtag
respiratori
viral
panel
fast
diagnosi
respiratori
viru
infect
j
clin
microbiol
pubm
abstract
publish
full
text
free
full
text
salez
n
vabret
leruezvil
et
al
evalu
four
commerci
multiplex
molecular
test
diagnosi
acut
respiratori
infect
plo
one
pubm
abstract
publish
full
text
free
full
text
choudhari
ml
anand
sp
tikh
sa
et
al
comparison
convent
multiplex
rtpcr
real
time
rtpcr
luminex
xtag
rvp
fast
assay
detect
respiratori
virus
j
med
virol
pubm
abstract
publish
full
text
rabaa
tue
nt
phuc
tm
et
al
vietnam
initi
zoonot
infect
vizion
strateg
approach
studi
emerg
zoonot
infecti
diseas
ecohealth
pubm
abstract
publish
full
text
free
full
text
la
van
doorn
hr
bryant
je
et
al
sensit
realtim
pcr
detect
subgroup
human
respiratori
syncyti
viru
j
virol
method
pubm
abstract
publish
full
text
free
full
text
jansen
rr
schinkel
j
koekkoek
et
al
develop
evalu
fourtub
real
time
multiplex
pcr
assay
cover
fourteen
respiratori
virus
comparison
correspond
singl
target
counterpart
j
clin
virol
pubm
abstract
publish
full
text
chen
jh
lam
hy
yip
cc
et
al
clinic
evalu
new
highthroughput
luminex
nxtag
respiratori
pathogen
panel
assay
multiplex
respiratori
pathogen
detect
j
clin
microbiol
pubm
abstract
publish
full
text
free
full
text
jokela
p
piiparinen
h
mannonen
l
et
al
perform
luminex
xtag
respiratori
viral
panel
fast
clinic
laboratori
set
j
virol
method
pubm
abstract
publish
full
text
tang
yw
gonsalv
sun
jy
et
al
clinic
evalu
luminex
nxtag
respiratori
pathogen
panel
j
clin
microbiol
pubm
abstract
publish
full
text
free
full
text
beckmann
c
hirsch
hh
compar
luminex
nxtagrespiratori
pathogen
panel
multiplex
detect
respiratori
pathogen
j
med
virol
pubm
abstract
publish
full
text
hang
vtt
ny
nth
phuc
tm
et
al
dataset
evalu
luminex
xtag
respiratori
viral
panel
fast
assay
detect
multipl
respiratori
viral
pathogen
nasal
throat
swab
vietnam
figshar
data
sourc
comment
agreement
method
mean
rang
found
viral
agent
luminex
assay
high
throughput
multiplex
platform
conclus
rapid
detect
common
viral
pathogen
caus
ari
although
current
high
cost
may
prevent
luminex
assay
wide
use
especi
limit
resourc
set
ari
felt
introduct
clinic
diagnost
may
help
reduc
unnecessari
use
antibiot
prescript
acut
respiratori
infect
ari
lead
caus
morbid
mortal
infant
children
worldwid
especi
southeast
asia
includ
vietnam
africa
vietnam
high
burden
ari
children
first
year
life
like
admit
intens
care
longer
hospit
stay
children
infecti
diagnos
virus
common
caus
ari
rapid
identif
caus
agent
therefor
clinic
public
health
signific
may
reduc
widespread
inappropri
use
antibiot
advanc
molecular
diagnost
provid
power
mean
detect
virus
term
sensit
specif
turnaround
time
equal
volum
vtm
nose
throat
swab
pool
subject
total
nucleic
acid
extract
addit
intern
control
eav
equin
arter
viru
refer
assay
bacteriophag
luminex
assay
use
magnapur
platform
roch
diagnost
mannheim
germani
accord
manufactur
instruct
extract
nucleic
acid
elut
ul
elut
buffer
store
analys
kit
provid
free
luminex
compani
real
time
multiplex
rtpcr
influenza
virus
infb
rv
target
test
specif
rtpcr
test
assay
detect
influenza
viru
perform
inhous
rtpcr
assay
use
primer
set
target
ha
haemagglutinin
gene
segment
forward
primer
revers
primer
probe
fam
black
hole
quencher
refer
consid
posit
one
refer
assay
posit
perform
luminex
assay
evalu
diagnost
yield
sensit
refer
assay
confid
interv
use
tabl
calcul
perform
intercool
stata
stata
colleg
station
tx
usa
agreement
luminex
refer
assay
determin
kappa
statist
use
spss
version
ibm
corp
spss
statist
ny
usa
mcnemar
test
spss
version
use
examin
whether
differ
diagnost
rate
individu
virus
luminex
refer
assay
statist
signific
set
p
total
sampl
collect
novemb
april
analys
evalu
luminex
assay
three
hundr
fortyeight
sampl
children
year
old
sampl
adult
malefemal
ratio
median
age
children
year
interquartil
rang
iqr
adult
year
iqr
overal
specimen
posit
either
luminex
refer
assay
one
hundr
forti
sampl
remain
undiagnos
entrhi
frequent
detect
pathogen
two
techniqu
total
count
pathogen
follow
hbov
n
n
less
frequent
detect
adv
n
hmpv
n
infa
n
hcov
n
rsv
b
n
n
infb
n
n
n
regard
mixedinfect
luminex
assay
also
detect
coinfect
compar
refer
assay
versu
maximum
number
pathogen
detect
singl
patient
parechovirus
detect
four
sampl
refer
assay
includ
luminex
assay
hcov
subtyp
refer
assay
also
detect
luminex
assay
true
posit
rate
sensit
refer
assay
gold
standard
pathogen
detect
luminex
detect
refer
correspond
addit
ci
posit
addit
pathogen
detect
refer
assay
detect
luminex
correspond
addit
ci
posit
individu
target
detect
rate
luminex
higher
target
rang
entrhi
adv
hmpv
infa
matrix
hcov
rsva
whilst
less
often
posit
hbov
rsvb
infb
vs
vs
vs
respect
remark
entrhi
detect
luminex
neg
refer
assay
among
clinic
swab
concord
two
techniqu
note
sampl
discord
record
sampl
show
substanti
agreement
overal
kappa
ci
tabl
also
show
test
agreement
viral
pathogen
almost
perfect
agreement
record
pathogen
hbov
infa
matrix
hcov
rsva
rsvb
infb
kappa
substanti
agreement
kappa
seen
hmpv
entrhi
adv
agreement
moder
kappa
fast
reliabl
diagnost
test
practic
need
help
physician
make
appropri
treatment
decis
use
tool
research
surveil
report
evalu
luminex
assay
respiratori
swab
collect
patient
admit
four
provinci
hospit
vietnam
lack
true
gold
standard
combin
number
publish
pcr
assay
refer
test
evalu
overal
posit
luminex
among
refer
assay
high
ci
besid
target
ent
rhi
adv
hmpv
often
detect
luminex
refer
assay
confirm
singlert
pcr
number
lref
case
rang
tabl
suggest
detect
use
luminex
superior
refer
assay
target
compar
refer
assay
studi
found
increas
detect
rate
luminex
target
signific
differ
seen
entrhi
lref
p
lref
respect
figur
especi
high
number
lref
entrhi
agent
show
consider
differ
studi
previou
xtag
luminex
studi
probabl
reveal
luminex
strong
assay
detect
viral
agent
meanwhil
detect
rate
hbov
significantli
higher
refer
assay
luminex
versu
figur
similar
previou
studi
sensit
luminex
viral
agent
rather
low
studi
respect
though
luminex
assay
may
benefit
diagnost
cost
treatment
requir
specif
instrument
detect
data
acquisit
therefor
may
appropri
laboratori
limit
equip
howev
highli
autom
system
capac
test
specimen
within
two
hour
includ
nucleic
acid
extract
handson
time
high
throughput
luminex
rvp
fast
method
would
use
larg
hospit
could
high
input
respiratori
sampl
run
batch
global
fear
clinic
worsen
patient
ari
usual
result
empir
antibiot
prescript
even
though
doctor
awar
ari
caus
virus
one
factor
contribut
long
interv
sampl
report
test
result
luminex
assay
may
part
solut
fast
turnaround
time
luminex
number
weak
distinguish
enteroviru
rhinoviru
quantit
compris
twotub
step
rtpcr
dna
hybrid
includ
opentub
step
transfer
pcr
product
rtpcr
tube
hybrid
tube
bring
risk
contamin
expens
significantli
lower
posit
rate
luminex
assay
hbov
found
studi
also
weak
kit
may
need
clinic
evalu
limit
studi
lack
true
gold
standard
commonli
seen
evalu
diagnost
assay
low
number
posit
sampl
sever
uncommon
virus
low
number
posit
sampl
may
conceal
true
diagnost
rate
virus
conclus
studi
show
luminex
rvp
fast
good
diagnost
perform
detect
multipl
respiratori
virus
result
studi
provid
addit
evalu
util
commerci
test
though
cost
luminex
assay
rather
high
luminex
rvp
fast
platform
could
becom
afford
larg
hospit
sampl
high
input
reduc
cost
test
batch
run
per
assay
cost
assay
becom
afford
advantag
short
turnaround
time
could
contribut
improv
patient
manag
chang
prescript
cultur
countri
like
vietnam
compet
interest
disclos
work
support
wellcom
trust
funder
role
studi
design
data
collect
analysi
decis
publish
prepar
manuscript
